Skip to main content

Advertisement

Log in

The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

To analyze the effects of extracellular matrix metalloproteinase inducer (CD147) on glioma proliferation, apoptosis, invasion, and angiogenesis. Tissue samples were obtained from 101 glioma cases while normal brain tissues were obtained from 30 brain injury cases. Immunohistochemical assay was performed to detect the expressions of CD147, CD34, and VEGF in tissue samples. QRT-PCR was performed to detect the relative expression of CD147 mRNA in human glioma cell lines. CD147 siRNA was transfected into glioma cell line U251. Cell proliferation, apoptosis, invasion, and angiogenesis were tested by MTT, flow cytometry, Transwell assay, and vasculogenic mimicry assay, respectively. Expressions of relative proteins were analyzed with western blot. CD147 was positively expressed with the percentage of 0, 37.5, 44.8, 67.9, and 85.7 % in normal tissues and glioma tissues with WHO grades I–IV, respectively, and the scores of MVDand VEGF were associated with the expression of CD147. CD147 was significantly upregulated in the human glioma cell lines (P < 0.05). Downregulated the expression of CD147 suppressed cell proliferation, blocked cell cycle, induced apoptosis, inhibited cell invasion and angiogenesis in glioma cells in vitro. The expression of CD147 was significantly associated with WHO tumor grade and angiogenesis; silencing of CD147 contributed to inhibition of glioma proliferation, invasion, and angiogenesis. Our study provided firm evidence that CD 147 is a potential glioma target for anti-angiogenic therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  2. Siegel R, Naishadham DandJemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29

    Article  PubMed  Google Scholar 

  3. Ostrom QT et al (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro-Oncol 16:896–913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Louis DN et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820

    Article  PubMed  Google Scholar 

  5. Stupp R, Hegi MandWeller M (2010) Neuro-oncology, a decade of temozolomide and beyond. Expert Rev Anticancer Ther 10:1675–1677

    Article  PubMed  Google Scholar 

  6. Stupp R et al (2010) Phase i/iia study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. J Clin Oncol Off J Am Soc Clin Oncol 28:2712–2718

    Article  CAS  Google Scholar 

  7. Tate MC, Aghi MK (2009) Biology of angiogenesis and invasion in glioma. Neurother J Am Soc Exp Neurother 6:447–457

    Article  CAS  Google Scholar 

  8. Cohen AL, Colman H (2015) Glioma biology and molecular markers. Cancer Treat Res 163:15–30

    Article  PubMed  Google Scholar 

  9. Zhao S et al (2013) Mir-106a is an independent prognostic marker in patients with glioblastoma. Neuro Oncol 15:707–717

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rosati A et al (2013) Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme. Neuro Oncol 15:618–625

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Sun C et al (2013) Antisense mmp-9 rna inhibits malignant glioma cell growth in vitro and in vivo. Neurosci Bull 29:83–93

    Article  CAS  PubMed  Google Scholar 

  12. Gu J et al (2009) Clinical implications and prognostic value of emmprin/cd147 and mmp2 expression in pediatric gliomas. Eur J Pediatr 168:705–710

    Article  CAS  PubMed  Google Scholar 

  13. Yu XL et al (2008) Crystal structure of hab18 g/cd147: implications for immunoglobulin superfamily homophilic adhesion. J Biol Chem 283:18056–18065

    Article  CAS  PubMed  Google Scholar 

  14. Weidle UH et al (2010) Cancer-related issues of cd147. Cancer Genom Proteom 7:157–169

    CAS  Google Scholar 

  15. Kanekura TandChen X (2010) Cd147/basigin promotes progression of malignant melanoma and other cancers. J Dermatol Sci 57:149–154

    Article  CAS  PubMed  Google Scholar 

  16. Tang Y et al (2004) Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (emmprin) expression and matrix metalloproteinase-dependent generation of soluble emmprin. Mol Cancer Res MCR 2:73–80

    CAS  PubMed  Google Scholar 

  17. Zhong X et al (2013) Overexpressions of rack1 and cd147 associated with poor prognosis in stage t1 pulmonary adenocarcinoma. Ann Surg Oncol 20:1044–1052

    Article  PubMed  Google Scholar 

  18. Bi XC et al (2012) Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas. Clin Transl Oncol Off Publ Feder Spanish Oncol Soc Nat Cancer Inst Mexico 14:190–196

    CAS  Google Scholar 

  19. Piao S et al (2012) Increased expression of cd147 and mmp-9 is correlated with poor prognosis of salivary duct carcinoma. J Cancer Res Clin Oncol 138:627–635

    Article  CAS  PubMed  Google Scholar 

  20. Wen PY, Kesari S (2008) Malignant gliomas in adults. The New England journal of medicine 359:492–507

    Article  CAS  PubMed  Google Scholar 

  21. Stupp R et al (2010) High-grade malignant glioma: esmo clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Euro Soc Med Oncol/ESMO 21(Suppl 5):v190–v193

    Article  Google Scholar 

  22. Zhao P et al (2015) Gsk-3beta regulates tumor growth and angiogenesis in human glioma cells. Oncotarget 6:31901–31915

    PubMed  PubMed Central  Google Scholar 

  23. Chen L et al (2016) Upregulation of mir-107 inhibits glioma angiogenesis and vegf expression. Cell Mol Neurobiol 36:113–120

    Article  CAS  PubMed  Google Scholar 

  24. Fan Y et al (2014) Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through hif-1alpha accumulation. Nat Cell Biol 16:445–456

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Vartanian A et al (2014) Gbm’s multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro-Oncol 16:1167–1175

    Article  PubMed  PubMed Central  Google Scholar 

  26. Van Meir EG et al (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60:166–193

    Article  PubMed  PubMed Central  Google Scholar 

  27. Chu T et al (2011) Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma. Pathol Oncol Res POR 17:705–711

    Article  CAS  PubMed  Google Scholar 

  28. Sameshima T et al (2000) Expression of emmprin (cd147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer 88:21–27

    Article  CAS  PubMed  Google Scholar 

  29. Nabeshima K et al (2006) Emmprin (basigin/cd147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 56:359–367

    Article  CAS  PubMed  Google Scholar 

  30. Liu F et al (2010) Expression of hab18 g is associated with tumor progression and prognosis of breast carcinoma. Breast Cancer Res Treat 124:677–688

    Article  CAS  PubMed  Google Scholar 

  31. Li Y et al (2012) Extracellular membrane-proximal domain of hab18 g/cd147 binds to metal ion-dependent adhesion site (midas) motif of integrin beta1 to modulate malignant properties of hepatoma cells. J Biol Chem 287:4759–4772

    Article  CAS  PubMed  Google Scholar 

  32. Liu Y et al (2013) Cd147, mmp9 expression and clinical significance of basal-like breast cancer. Med Oncol 30:366

    Article  PubMed  Google Scholar 

  33. Liang Q et al (2005) Inhibition of basigin expression in glioblastoma cell line via antisense rna reduces tumor cell invasion and angiogenesis. Cancer Biol Ther 4:759–762

    Article  CAS  PubMed  Google Scholar 

  34. Miranda-Goncalves V et al (2013) Monocarboxylate transporters (mcts) in gliomas: expression and exploitation as therapeutic targets. Neuro-Oncol 15:172–188

    Article  CAS  PubMed  Google Scholar 

  35. Fei F et al (2015) The roles of cd147 in the progression of gliomas. Expert Rev Anticancer Ther 15:1351–1359

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xuan Chen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yin, H., Shao, Y. & Chen, X. The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma. Neurol Sci 38, 129–136 (2017). https://doi.org/10.1007/s10072-016-2727-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2727-2

Keywords

Navigation